Pharmacist Digest

Osivax publishes phase 2a results supporting dual flu vaccine approach

Pharma Times

JULY 10, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Osivax publishes phase 2a results supporting dual flu vaccine approach by John Pinching | 10th Jul 2025 | News OVX836 shown to be safe and effective alongside seasonal Fluarix Tetra Osivax has released phase 2a trial data confirming that its broad-spectrum flu vaccine candidate, OVX836, can be safely co-admin

Vaccines

Vaccines Immunization Immunity

MHRA approves first oral treatment for hereditary angioedema attacks

Pharma Times

JULY 15, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership MHRA approves first oral treatment for hereditary angioedema attacks by John Pinching | 15th Jul 2025 | News Sebetralstat offers injection-free relief for patients aged 12 and over The MHRA has approved sebetralstat (Ekterly) as the first oral, on-demand treatment for hereditary angioedema (HAE) attacks in pa

Pierre Fabre secures China approval for BRAFTOVI combination in colorectal cancer

Pharma Times

JULY 14, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Pierre Fabre secures China approval for BRAFTOVI combination in colorectal cancer by John Pinching | 14th Jul 2025 | News New treatment targets BRAFV600E-mutant mCRC after prior therapy Pierre Fabre Laboratories have received marketing authorisation in China for BRAFTOVI (encorafenib) in combination with cetu

Vaccines

Government to adopt EU standards for high-risk diagnostic devices

Pharma Times

JULY 10, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Government to adopt EU standards for high-risk diagnostic devices by John Pinching | 10th Jul 2025 | News New regulations aim to simplify processes and strengthen patient safety The Government is set to amend UK medical devices regulations by adopting EU Common Specifications for high-risk in vitro diagnostic

Vaccines

Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression

Pharma Times

JULY 17, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression by John Pinching | 17th Jul 2025 | News First patient dosed in BUOY-1 study targeting MDD with or without anxious distress Seaport Therapeutics has dosed the first patient in its phase 2b BUOY-1 trial of GlyphAllo, a novel oral prodr

Labelling

NHS England secures access to new cystic fibrosis treatment ALYFTREK

Pharma Times

JULY 15, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership NHS England secures access to new cystic fibrosis treatment ALYFTREK by John Pinching | 15th Jul 2025 | News Vertex’s once-daily triple therapy approved for eligible patients aged six and over Vertex Pharmaceuticals has announced a broad reimbursement agreement with NHS England for ALYFTREK (deutivacaftor/tez

Moderna flu vaccine shows superior results in phase 3 study

Pharma Times

JULY 1, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Moderna flu vaccine shows superior results in phase 3 study by John Pinching | 1st Jul 2025 | News Data shows mRNA-1010 could better protect adults aged 50 and above Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose licensed influenza vac

Vaccines

Vaccines Adverse Reactions

AviadoBio opens UK trial for FTD gene therapy

Pharma Times

MAY 15, 2025

Aspire-FTD study aims to stop disease progression with one-time treatment

2025 PharmaTimes Clinical Researcher of the Year

Pharma Times

JUNE 24, 2025

Enter this year's famous competition

Lumanity and Parker Institute partner to support delivery of new immunotherapies

Pharma Times

MAY 29, 2025

The alliance combines Lumanitys commercial and development strategy capabilities with PICIs translational research expertise

PharmaTimes Clinical Researcher of the Year – The Americas

Pharma Times

JUNE 9, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs PharmaTimes Clinical Researcher of the Year – The Americas by John Pinching | 9th Jun 2025 | News Enter The 2025 PharmaTimes Clinical Researcher of the Year – The Americas!

Excellence in Healthcare Partnerships Awards launched by PMGroup and Visions4Health

Pharma Times

JUNE 24, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Excellence in Healthcare Partnerships Awards launched by PMGroup and Visions4Health by Emily Kimber | 24th Jun 2025 | News The programme was unveiled at this year’s NHS ConfedExpo in Manchester PMGroup Worldwide and Visions4Health have launched the Excellence in Healthcare Partnerships (EHP) Awards to re

Diabetes

Diabetes Hospitals

PharmaTimes Clinical Researcher of the Year – The Americas

Pharma Times

JUNE 3, 2025

Enter The 2025 PharmaTimes Clinical Researcher of the Year The Americas!

Tagomics secures £860k grant for colorectal cancer test

Pharma Times

JUNE 10, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Tagomics secures £860k grant for colorectal cancer test by John Pinching | 10th Jun 2025 | News Biotech firm to collaborate with NHS on early detection study Tagomics has been awarded £860k in funding from Innovate UK’s Biomedical Catalyst programme to develop a novel diagnostic test for colorectal cance

One Biosciences raises €15 million to advance single-cell oncology platform

Pharma Times

JULY 17, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership One Biosciences raises €15 million to advance single-cell oncology platform by John Pinching | 17th Jul 2025 | News Funding to accelerate development of AI-driven tumour profiling tool OneMap One Biosciences has secured €15 million in Series A financing to expand its AI-powered single-cell transcriptomic plat

Drug Development

Imperial study reveals DNA structure that could reverse ovarian cancer resistance

Pharma Times

JULY 14, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Imperial study reveals DNA structure that could reverse ovarian cancer resistance by John Pinching | 14th Jul 2025 | News Targeting G-quadruplexes may restore chemotherapy effectiveness Researchers at Imperial College London have discovered that an unusual DNA structure could be key to reversing chemotherapy

Chemotherapy

Chemotherapy Vaccines

Levicept presents new LEVI-04 data at EULAR

Pharma Times

JUNE 12, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Levicept presents new LEVI-04 data at EULAR by John Pinching | 12th Jun 2025 | News Biotech firm shares phase 2 findings on novel osteoarthritis treatmen Levicept has presented new data from its phase 2 trial of LEVI-04 at the European Congress of Rheumatology (EULAR 2025).

Argenx presents new efgartigimod data at EULAR 2025

Pharma Times

JUNE 11, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Argenx presents new efgartigimod data at EULAR 2025 by John Pinching | 11th Jun 2025 | News Rheumatology studies show promising results for Sjogren’s disease Argenx has presented positive phase 2 results for efgartigimod in myositis and Sjogren’s disease at EULAR 2025.

Bimekizumab shows lasting efficacy at EULAR 2025

Pharma Times

JUNE 11, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Bimekizumab shows lasting efficacy at EULAR 2025 by John Pinching | 11th Jun 2025 | News Three-year data highlights inflammation control in psoriatic arthritis UCB has announced new three-year data from phase 3 trials and their open-label extensions investigating BIMZELX (bimekizumab) in psoriatic arthri

Labelling

Labelling Hospitals

Investigational treatment shows promise for aggressive multiple myeloma

Pharma Times

JUNE 16, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Investigational treatment shows promise for aggressive multiple myeloma by John Pinching | 16th Jun 2025 | News Results suggest bispecific antibody combination could improve outcomes A new investigational treatment has shown strong and lasting responses in multiple myeloma patients with extramedullary di

North East NHS launches digital platform to tackle chronic kidney disease

Pharma Times

JULY 16, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership North East NHS launches digital platform to tackle chronic kidney disease by John Pinching | 16th Jul 2025 | Uncategorized , News Healthinote rollout aims to improve early detection and patient self-management North East and North Cumbria NHS has begun a year-long rollout of the Healthinote digital health pla

Eli Lilly acquires SiteOne Therapeutics to advance treatment for chronic pain

Pharma Times

MAY 28, 2025

Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of non-opioid medicines to treat pain and other neuronal hyperexcitability disorders, to advance SiteOnes leading asset STC-004. Lilly will lead STC-004 through phase 2 trials and commercialisation for global markets.

Kaerus Bioscience secures orphan drug designation for fragile x syndrome treatment

Pharma Times

MAY 14, 2025

FDA recognises KER-0193 as a potential therapy for rare paediatric disease

Proximie and HistoSonics partner to transform liver tumour treatment in US

Pharma Times

JULY 16, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Proximie and HistoSonics partner to transform liver tumour treatment in US by John Pinching | 16th Jul 2025 | News Digital operating rooms and histotripsy therapy combine to improve outcomes Proximie has announced a new partnership with HistoSonics to support the rollout of the Edison Histotripsy System acros

Hospitals

NHS rolls out new initiative to identify pancreatic cancer earlier

Pharma Times

JUNE 23, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs NHS rolls out new initiative to identify pancreatic cancer earlier by Emily Kimber | 23rd Jun 2025 | News The pilot will see GP practices look at patient records to identify those most at risk The NHS has announced the launch of a new initiative aimed at identifying pancreatic cancer in its earliest stag

Diabetes

Diabetes Hospitals

FDA approves UroGen’s Zusduri to treat recurrent bladder cancer

Pharma Times

JUNE 17, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs FDA approves UroGen’s Zusduri to treat recurrent bladder cancer by Emily Kimber | 17th Jun 2025 | News Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US The US Food and Drug Administration (FDA) has approved UroGen Pharma’s Zusduri (mitomycin intravesical solutio

Linear Diagnostics awarded £1m to develop rapid STI test

Pharma Times

JUNE 5, 2025

New funding supports development of diagnostic platform

EC approves Santen’s Ryjunea to slow progression of paediatric myopia

Pharma Times

JUNE 5, 2025

Therapy indicated for children aged 3 to 14 at treatment initiation

Oxford Brain Diagnostics to launch groundbreaking dementia diagnosis technology

Pharma Times

MAY 26, 2025

Company secures regulatory approvals for commercial rollout in UK and US

NICE recommends sparsentan for IgA nephropathy

Pharma Times

MAY 26, 2025

First non-immunosuppressive dual-action therapy approved for eligible patients

MHRA approves guselkumab for Crohn’s disease and ulcerative colitis

Pharma Times

MAY 19, 2025

Regulator confirms safety and efficacy of new treatment option for patient

iOnctura starts randomised phase 1/2 trial in lung cancer treatment

Pharma Times

MAY 8, 2025

Study explores whether PI3K targeting could combat resistance

NICE recommends mirikizumab for Crohn’s disease treatment

Pharma Times

JUNE 2, 2025

New guidance expands treatment options for eligible patients

AstraZeneca’s Forxiga recommended for chronic kidney disease treatment

Pharma Times

JUNE 2, 2025

Updated guidance from NICE expands eligibility for dapagliflozin us

TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform

Pharma Times

MAY 28, 2025

TQ Therapeutics (TQx) has acquired Juno Therapeutics GmbH, the German subsidiary of Juno Therapeutics, through a share purchase agreement. Juno GmbH was previously owned by Bristol Myers Squibb. Financial terms have not been disclosed.

Sonrai and AOA Dx partner to accelerate ovarian cancer test development

Pharma Times

MAY 22, 2025

Strategic collaboration aims to improve early diagnosis

MHRA Board meets in Scotland for first time, reinforcing UK-wide health priorities

Pharma Times

MAY 22, 2025

The Board of the Medicines and Healthcare products Regulatory Agency (MHRA) has met in Scotland for the first time, marking a significant step in the agencys approach to delivering health and innovation priorities across the UK.

Herantis Pharma doses final cohort in phase 1b trial of HER-096 for Parkinson’s disease

Pharma Times

MAY 14, 2025

Trial progresses towards topline data expected later in the year

Amgen’s Tepezza granted marketing authorisation in the UK

Pharma Times

MAY 8, 2025

Teprotumumab approved as first targeted treatment for thyroid eye disease

Johnson & Johnson submits application for subcutaneous Rybrevan dosing

Pharma Times

MAY 6, 2025

Company seeks approval for new schedules to improve patient convenience

Chiesi partners with Wirral Primary Care to improve COPD detection

Pharma Times

MAY 6, 2025

New initiative aims to accelerate diagnosis and ease NHS pressures

NHS ConfedExpo 2025: a platform for change in UK health and care

Pharma Times

JUNE 25, 2025

This year's event took place on 11 to 12 June at Manchester Central

EDX medical partners with spire healthcare to advance disease diagnostics

Pharma Times

JUNE 16, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs EDX medical partners with spire healthcare to advance disease diagnostics by John Pinching | 16th Jun 2025 | News Collaboration aims to improve rapid detection and personalised treatments EDX Medical Group has entered into an agreement with Spire Healthcare Group to advance diagnostic innovations aimed a

Migraine takes the spotlight at European Parliament

Pharma Times

JUNE 12, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Migraine takes the spotlight at European Parliament by John Pinching | 12th Jun 2025 | News EMHA calls for its inclusion in EU neurological health strategy The European Migraine and Headache Alliance (EMHA) has urged EU policymakers to include migraine in the forthcoming Neurological Health Strategy.

Pharma Times

Osivax publishes phase 2a results supporting dual flu vaccine approach

MHRA approves first oral treatment for hereditary angioedema attacks

Trending Sources

Pierre Fabre secures China approval for BRAFTOVI combination in colorectal cancer

Government to adopt EU standards for high-risk diagnostic devices

Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression

NHS England secures access to new cystic fibrosis treatment ALYFTREK

Moderna flu vaccine shows superior results in phase 3 study

AviadoBio opens UK trial for FTD gene therapy

2025 PharmaTimes Clinical Researcher of the Year

Lumanity and Parker Institute partner to support delivery of new immunotherapies

PharmaTimes Clinical Researcher of the Year – The Americas

Excellence in Healthcare Partnerships Awards launched by PMGroup and Visions4Health

PharmaTimes Clinical Researcher of the Year – The Americas

Tagomics secures £860k grant for colorectal cancer test

One Biosciences raises €15 million to advance single-cell oncology platform

Imperial study reveals DNA structure that could reverse ovarian cancer resistance

Levicept presents new LEVI-04 data at EULAR

Argenx presents new efgartigimod data at EULAR 2025

Bimekizumab shows lasting efficacy at EULAR 2025

Investigational treatment shows promise for aggressive multiple myeloma

North East NHS launches digital platform to tackle chronic kidney disease

Eli Lilly acquires SiteOne Therapeutics to advance treatment for chronic pain

Kaerus Bioscience secures orphan drug designation for fragile x syndrome treatment

Proximie and HistoSonics partner to transform liver tumour treatment in US

NHS rolls out new initiative to identify pancreatic cancer earlier

FDA approves UroGen’s Zusduri to treat recurrent bladder cancer

Linear Diagnostics awarded £1m to develop rapid STI test

EC approves Santen’s Ryjunea to slow progression of paediatric myopia

Oxford Brain Diagnostics to launch groundbreaking dementia diagnosis technology

NICE recommends sparsentan for IgA nephropathy

MHRA approves guselkumab for Crohn’s disease and ulcerative colitis

iOnctura starts randomised phase 1/2 trial in lung cancer treatment

NICE recommends mirikizumab for Crohn’s disease treatment

AstraZeneca’s Forxiga recommended for chronic kidney disease treatment

TQ Therapeutics acquires Juno GmbH to support decentralised cell therapy platform

Sonrai and AOA Dx partner to accelerate ovarian cancer test development

MHRA Board meets in Scotland for first time, reinforcing UK-wide health priorities

Herantis Pharma doses final cohort in phase 1b trial of HER-096 for Parkinson’s disease

Amgen’s Tepezza granted marketing authorisation in the UK

Johnson & Johnson submits application for subcutaneous Rybrevan dosing

Chiesi partners with Wirral Primary Care to improve COPD detection

NHS ConfedExpo 2025: a platform for change in UK health and care

EDX medical partners with spire healthcare to advance disease diagnostics

Migraine takes the spotlight at European Parliament

Stay Connected